FDA inspection
GlaxoSmithKline Biologicals: FDA inspection ending Mar 12, 2024
FDA inspection 1232702 · Voluntary Action Indicated (VAI) · Saint-Amand-Les-Eaux
Key facts
| Inspection ID | 1232702 |
|---|---|
| Firm | GlaxoSmithKline Biologicals |
| FEI number | 3014752610 |
| Address | 637 Rue Des Aulnois |
| City | Saint-Amand-Les-Eaux |
| Country | France |
| Fiscal year | 2024 |
| Inspection end date | Mar 12, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Vaccines and Allergenic Products |
| Product type | Biologics |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data